INFINITY PHARMACEUTICALS, INC. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Infinity Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q2 2023.
  • Infinity Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2023 was $493K, a 44.4% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 $493K -$394K -44.4% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $597K -$380K -38.9% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $697K -$367K -34.5% Dec 31, 2022 10-Q 2023-08-10
Q3 2022 $793K -$345K -30.3% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $887K -$357K -28.7% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $977K -$359K -26.9% Mar 31, 2022 10-Q 2022-05-03
Q4 2021 $1.06M -$355K -25% Dec 31, 2021 10-K 2023-03-28
Q3 2021 $1.14M -$348K -23.4% Sep 30, 2021 10-Q 2021-11-02
Q2 2021 $1.24M -$339K -21.4% Jun 30, 2021 10-Q 2021-07-27
Q1 2021 $1.34M -$325K -19.6% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $1.42M -$298K -17.4% Dec 31, 2020 10-K 2022-03-29
Q3 2020 $1.49M -$240K -13.9% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $1.58M -$199K -11.2% Jun 30, 2020 10-Q 2020-07-30
Q1 2020 $1.66M +$1.54M +1229% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $1.72M Dec 31, 2019 10-K 2021-03-16
Q3 2019 $1.73M Sep 30, 2019 10-Q 2019-10-30
Q2 2019 $1.78M Jun 30, 2019 10-Q 2019-07-30
Q1 2019 $125K Mar 31, 2019 10-Q 2019-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.